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Background: Recently socioeconomic status (SES) and job stress index received more attention to affect mental
health. Folate intake has been implicated to have negative association with depression. However, few studies were
published for the evidence association together with the consideration of SES and job stress factors. The current
study is a part of the Japanese study of Health, Occupation and Psychosocial factors related Equity (J-HOPE study)
that focused on the association of social stratification and health and our objective was to clarify the association
between folate intake and depressive symptoms in Japanese general workers.
Methods: Subjects were 2266 workers in a Japanese nationwide company. SES and job stress factors were assessed
by self-administered questionnaire. Folate intake was estimated by a validated, brief, self-administered diet history
questionnaire. Depressive symptoms were measured by Kessler’s K6 questionnaire. “Individuals with depressive
symptoms” was defined as K6≧9 (in K6 score of 0–24 scoring system). Multiple logistic regression and linear
regression model were used to evaluate the association between folate and depressive symptoms.
Results: Several SES factors (proportion of management positions, years of continuous employment, and annual
household income) and folate intake were found to be significantly lower in the subjects with depressive symptom
(SES factors: p< 0.001; folate intake: P= 0.001). There was an inverse, independent linear association between K6
score and folate intake after adjusting for age, sex, job stress scores (job strains, worksite supports), and SES factors
(p= 0.010). The impact of folate intake on the prevalence of depressive symptom by a multiple logistic model was
(ORs[95% CI]: 0.813 [0.664-0.994]; P =0.044).
Conclusions: Our cross-sectional study suggested an inverse, independent relation of energy-adjusted folate intake
with depression score and prevalence of depressive symptoms in Japanese workers, together with the
consideration of SES and job stress factors.Background
Depression is the most common psychiatric condition
and regarded as a major cause of disability worldwide. In
Japan, the life time prevalence of major depression has
been estimated at 3-7% [1]. The presence of depressive
symptoms considerably increases the risk of major de-
pression. Among many putative risk factors, folate defi-
ciency has been recognized since the 1960s as an* Correspondence: miyaki-keio@umin.net
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reproduction in any medium, provided the orimportant contributor to the depression [2,3]. A lot of
studies examining the risk of depression in the presence
of low folate were performed [4-8], including in Japanese
subjects. In 2006, Gilbody reported that there is accu-
mulating evidence that low folate status is associated
with depression by meta-analysis [9]. Contrast to that in
these observational studies, the effects of folate supple-
mentation on depressive symptomatology obtained from
several intervention studies were inconsistent, Taylor et
al. performed a systematic review and meta-analysis then
suggested that folate may have a potential role as a sup-
plement to other treatment for depression [10], although
another study failed to provide evidence for theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vitamin B12 supplementation [11].
Another risk factor of depression is low socioeconomic
status (SES) [12,13]. Low-SES groups are often exposed
to an accumulation of life event stressors and chronic
problems related to their low-SES state, such as poor
education, poor labor circumstances and unemployment,
financial strain, inadequate housing, or neighbor vio-
lence. In 2003, V. Lorant reported socioeconomic in-
equality in depression by meta-analysis [14]. In their
report, 51 studies reported an odds ratio greater than 1,
of which 35 were statistically significant.
Workplace mental health has also garnered increasing
attention over the past decade because depressive disor-
ders are highly prevalent in the workplace and have an
enormously negative impact on performance, productiv-
ity, absenteeism and disability costs. Several studies have
found significant associations between sources of per-
ceived stress and major depression onset [15-17], sug-
gesting that work stress is an independent risk factor for
the development of depression. The Job Demand-Con-
trol -Support (JDCS) model has dominant research on
occupational stress in which three major components
are used to describe workplace qualities: demands, con-
trol, and support [18]. Sanne et al. showed that high
demands, low control and low support individually, but
particularly combined, are risk factors for anxiety and
depression [19].
Folate has been implicated to have negative association
with depression, but to our knowledge, the contribution
of the SES or job stress factors is still unclear. Recently,
the Japanese study of Health, Occupation and Psycho-
social factors related Equity (J-HOPE study) was per-
formed to develop and expand research to elucidate
mechanisms underlying the social disparity in health and
establishment of measures to control over it. The
current study is a part of the J-HOPE, and our objective
of this study was to clarify the association between folate
intake and depressive symptoms in Japanese general
workers by using large-scale samples, together with the
consideration of SES and job stress factors.
Methods
Subjects
The present cross-sectional study was based on a baseline
survey of our occupational cohort study on social class and
health, supported by a grant from the Ministry of Educa-
tion, Culture, Sports, Science and Technology, Japan. Em-
ployee of a Japanese major manufacturing company
(Headquarter is in Kyoto and the other major 11 offices
were spread all over the Japan) were recruited. All workers
were invited to participate, and 2266 agreed (aged from
21–65 years; response rate 90.1%). 241 of them are women
and account for 10.6%. The protocol and explanationdocuments of our study were approved by the ethics com-
mittee of University of Tokyo School of Medicine, and writ-
ten informed consent was obtained from each subject.
Measurements
Height, weight, systolic and diastolic blood pressures,
fasting blood glucose level, serum lipid levels (total chol-
esterol, triglyceride, high density lipoprotein [HDL] chol-
esterol), aspartate aminotransferase (AST), alanine
aminotransferase (ALT), gamma-glutamyl transpeptidase
(gamma-GTP), blood urea nitrogen (BUN), serum cre-
atinine (Cr), and serum uric acid (UA) levels were mea-
sured in health checkups in all subjects.
Depressive symptom was assessed by using the Kessler
6 (K6) scale [20]. K6 scale is a 6-question scale to quantify
the non-specific psychological distress and now is used in
clinical populations to identify those people who have a
serious mental illness. It comes in a self-administered ver-
sion and an interviewer-administered version [21] and is
ideal for monitoring prevalence of depressive disorders on
a large scale. In the current study, the self-administered
version was used. The Japanese version of K6 scale was
developed by using the standard back-translation method
and included in the World Mental Health Survey Japan
(WMH-J) [22]. The WMH-J used the WMH Survey Ini-
tiative version of the Composite International Diagnostic
Interview (CIDI) to assess the 30-day Diagnostic and Stat-
istical Manual of Mental Disorders–Fourth Edition (DSM-
IV). This version demonstrated screening performances
equivalent to that of the original English version. There
are two scoring systems for K6 based on responses of “1-
5” or “0-4”, resulting in score ranges of 0–24 or 6–30, re-
spectively. In the current study we used the 24-scoring
system. A cut-offs of ≥9 for the K6 for identifying subjects
at high risk of depressive symptom was suggested accord-
ing to a validation report, in which the sensitivity and spe-
cificity were estimated at 77.8 and 86.4 in Japanese
population [23].
Job strain score is defined as a ratio of job demands to
job control followed by multiplied by 2 in order to adjust
for the difference in scoring ranges between the job de-
mand scale (12–48) and the job control scale (24–96)
[24]. Worksite support score is calculated by adding the
scores of supervisor support and colleague support. Job
demands and control, supervisor support and colleague
support were obtained from a self-administered ques-
tionnaire. Years of education, annual household income,
and the number of household were assessed by the same
self-administered questionnaire as above.
Dietary intake
Dietary habits during the preceding month were assessed
with a validated, brief, self-administered diet history ques-
tionnaire (BDHQ) [25].
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and, where necessary, clarified by direct questioning of the
subject. The BDHQ is a 4-page structured questionnaire
that enquires about the consumption frequency of a total
of 56 food and beverage items, with specified serving sizes
described in terms of the natural portion or the standard
weight and volume measurement of servings commonly
consumed in general Japanese populations. The BDHQ
was developed based on a comprehensive (16-page) ver-
sion of a validated self-administered diet history question-
naire [26-28]. The BDHQ includes the main food sources
for the Japanese with regard to folate (vegetables [nine
items: lettuces; tomatoes; dark-green leafy vegetables; cab-
bages; carrots and pumpkins; radishes and turnips; onions,
burdocks, and lotus roots; mushrooms; and seaweeds] and
green tea [one item]). The validation of the BDHQ was
performed by using 16-d weighed dietary records as the
gold standard [25], and Pearson correlation coefficients
for folate intake in 92 Japanese men and 92 Japanese
women aged from 31 to 76 years were 0.50 and 0.62, re-
spectively. Adjusted folate intake was calculated as daily
folate intake divided by daily total calories (per 1000Kcal).
Statistics
Student’sT test or Mann-Whitney’s U test was applied
to compare variables between groups after Levine’s test
for equality of variance. Difference in more than 2
groups was assessed using Turkey’s post hoc test of ana-
lysis of variance (ANOVA). Odds ratios (ORs) and 95%
confidence intervals (95% CIs) were calculated using lo-
gistic regression analysis. All statistical analyses were
performed using SPSS for Windows version 19.0 J (IBM
Corporation, New York, USA). Statistical significance
was accepted for a two-tailed p-value of < 0.05.
Results
In Table 1, the basic characteristics, SES factors and job
stressor scores of the study subjects are shown. The mean
(± standard deviation, SD) age and body mass index
(BMI) of the total subjects (n= 2266) were 43.5 ± 9.8 years
and 23.1± 3.3 kg/m2, respectively, which are typical for
middle-aged Japanese. 495 subjects (21.8%) had a K6 score
more than 9 and they were defined as with depressive
symptom. The incidences in male and female subjects
were 22.2% and 19.0%, respectively. Comparison of sub-
jects with and without depressive symptom revealed that
the subjects with depressive symptom were significantly
younger than those without (41.7 ± 9.3 years vs.
44.0± 9.8 years, P< 0.001). There were no significant dif-
ferences in clinical characteristics including BMI, blood
pressure, serum lipid profiles and fasting plasma glucose
between these two groups.
As to SES factors, proportion of management positions,
years of continuous employment, and unadjusted annualhousehold income were found to be significantly lower in
the subjects with depressive symptom. Also the daily fol-
ate intake levels adjusted by total energy intake were sig-
nificantly different between two groups (155.8± 54.7 vs
165.0 ± 57.4 μg/1000 kcalday, P=0.001), although the un-
adjusted folate intake were not different (P=0.162).
For job stressor scores, notable differences were found
between subjects with or without depressive symptom in
job demands, control, strain and worksite supports. All
of the P values were less than 0.001.
The relationship between K6 score - the measurement
of depressive symptom, and dietary folate intake level,
was further assessed by linear regression model. The as-
sociation of K6 score with folate intake as a continuous
variable is shown in Table 2. When the analysis was con-
ducted by using single factor, age, job strain, worksite
support, proportion of management position, annual
household income and energy-adjusted folate intake cor-
related to K6 scores, suggesting the real association with
depression of each factor (For folate intake, β=−0.077, P
<0.001, other data are not shown). If the adjusted factors
include age and sex only, the relation remains significant
with a P value for trend as 0.002 (β=−0.067). There was
an inverse linear association between K6 score and folate
intake, P value was 0.010 after adjusting for age, sex, job
stress score (job strain and worksite support) and SES
factors (years of education, proportion of management
position and annual household income). In addition, age
and both of the stressor scores were also associated with
K6 score (P <0.001). In this study, neither of the SES fac-
tors influenced on K6 score. Even if the effects of con-
founding factors such as SES factors and job stress were
considered, our results provided the evidence for the
robust correlation between folate intake and depression.
When the subjects were classified into tertiles accord-
ing to energy-adjusted folate intake level, mean K6 score
(±standard error of the mean [SEM]) of each subgroup
adjusted for age, sex, job strain, worksite support, years
of education, proportion of management position and
annual household income was calculated and compared.
The adjusted mean values were 5.5 ± 0.2, 5.2 ± 0.2 and
4.8 ± 0.2, respectively. P value for the trend was less than
0.001, indicating a significant linear reduction of K6
score with the increasing of folate intake (Figure 1).
We also considered the gender difference on this asso-
ciation. By the separate linear regression analysis per-
formed in two genders, the association between energy-
adjusted folate intake and K6 score remained in male
subjects (β=−0.050, P= 0.021), but disappeared in
females (β=−0.054, P= 0.412).
Multiple logistic regression was also performed to
examine whether the prevalence of depressive symptom
relates to folate intake level. According to the result
shown in Table 3, if the folate intake increases 100 μg











Age (year) 43.5 ± 9.8 44.0 ± 9.8 41.7 ± 9.3 <0.001**
Proportion of women (%) 10.6 11.0 9.3 0.273
Body mass index (kg/m2) 23.1 ± 3.3 23.0 ± 3.2 23.3 ± 3.5 0.209
Baseline characteristics
Systolic blood pressure (mmHg) 123.4 ± 16.1 123.7 ± 16.1 122.2 ± 16.0 0.081
Diastolic blood pressure (mmHg) 77.1 ± 12.0 77.1 ± 12.0 77.0 ± 11.9 0.760
Total cholesterol (mg/dL) 200.0 ± 35.1 200.2 ± 35.2 199.1 ± 34.5 0.582
Triglyceride (mg/dL) 125.8 ± 180.0 125.4 ± 195.3 127.4 ± 104.5 0.840
HDL cholesterol (mg/dL) 61.8 ± 16.5 62.0 ± 16.3 61.2 ± 17.4 0.424
Fasting plasma glucose (mg/dL) 95.0 ± 23.2 95.1 ± 21.7 94.9 ± 28.0 0.933
AST (IU/L) 23.7 ± 18.3 23.6 ± 19.7 24.0 ± 11.8 0.752
ALT (IU/L) 25.8 ± 18.1 25.5 ± 18.1 26.7 ± 18.0 0.245
γ-GTP (IU/L) 47.4 ± 56.8 47.1 ± 55.9 48.5 ± 60.2 0.676
SES factors
Years of education (year) 14.5 ± 2.5 14.6 ± 2.5 14.4 ± 2.5 0.320
Proportion of management position (%) 22.7 24.4 16.6 <0.001**
Years of continuous employment (year) 20.6 ± 11.6 21.1 ± 11.7 19.2 ± 11.1 0.001**
Working hours (hour/week) 46.6 ± 7.2 46.5 ± 7.1 47.0 ± 7.6 0.185
Annual household income (ten thousands yen/year) 704.4 ± 297.5 717.9 ± 303.3 656.3 ± 270.7 <0.001**
Adjusted annual household income (ten thousands yen/year) 443.0 ± 188.5 446.1 ± 188.7 431.8 ± 187.7 0.134
Number of families (n) 2.9 ± 1.4 2.9 ± 1.4 2.8 ± 1.5 0.018*
Job stress scores
Job Demands 4.7 ± 2.5 4.5 ± 2.4 5.5 ± 2.6 <0.001**
Job Control 3.0 ± 1.4 3.0 ± 1.4 2.7 ± 1.4 <0.001**
Job Strain 4.0 ± 3.4 3.7 ± 3.1 5.2 ± 4.0 <0.001**
Worksite Support 11.8 ± 1.8 11.9 ± 1.6 11.3 ± 2.0 <0.001**
K6 Score 5.1 ± 4.6 3.2 ± 2.6 12.2 ± 3.3 <0.001**
Daily folate intake (μg/day) 295.6 ± 127.3 297.6 ± 125.9 288.5 ± 131.9 0.162
Energy-adjusted folate intake (μg/1000 kcalday) 163.0 ± 56.9 165.0 ± 57.4 155.8 ± 54.7 0.001**
Values are shown as mean ± standard deviation or percentage. Subjects with or without depressive mood were compared. Depressive symptom is defined as K6
score ≥9 in a 24-scoring system.
Job strain ratio is defined as a ratio of job demands to job control followed by multiplied by 2. Worksite support score is calculated by adding the scores of
supervisor support and colleague support.
For continuous variables we used Student’s T test or Mann–Whitney U test. As to the categorized variables, we used χ2 test.
*P <0.05; **P< 0.01.
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sive reduced approximately 19% (95% CI: 0.664-0.994;
P= 0.044). Meanwhile age and worksite support also
decreased the risk of depressive symptom, however, high
job strain did oppositely.
Discussion
In the current study, we confirmed an inverse, inde-
pendent linear relation of K6 score with the energy-adjusted folate intake level in Japanese workers. These
results are in agreement with previous study of Japanese
[5,29]. It is worthy of note that comparing with the small
sample size of their studies (517 in Ref. 5 and 530 in Ref.
29), our study was a large-scale investigation with more
than 2,200 participants, providing more convincing evi-
dence for this association. Furthermore, we took various
job stress scores into account as potential relative factors
at the first time. When the job stress scores were not
Table 2 Association of energy-adjusted folate intake with
K6 score by linear regression models
Energy-adjusted folate intake Standard β P value
Model 1 −0.077 <0.001**
Model 2 −0.067 0.002**
Model 3 −0.054 0.010*
P values (β coefficients) showing the significance for linear regression analysis
are present. P for model <0.001. *P <0.05; **P< 0.01.
In Model 1, the unadjusted P value for the association between K6 score and
energy-adjusted folate intake is shown. In Model 2, P value is adjusted for age
and sex only. In model 3, adjust factors include age, sex, job stress scores and
SES factors.
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factors only, the folate intake was also associated with
K6 score by linear regression (standard β was −0.059; P
value for trend was 0.006) and prevalence of depressive
symptom by logistic regression (ORs [95% CI]: 0.813
[0.671-0.985]; P value was 0.035). After further adjusted
for the job stress scores, the relations of folate intake to
K6 score and prevalence of depressive symptom
remained (P values are 0.010 and 0.044, respectively),
and the stress factors also showed association with de-
pressive symptom, providing inspiration to understand
thoroughly the relationships among depression and rela-
tive factors.
The results that the association between folate intake
and depressive mood was found in men only, were con-
sistent with that of Murakami et al. [5] and Nanri et al.
[29], who found that higher folate intake was associated
with lower prevalence of depressive symptoms in Japa-
nese men but not in women, although in another study
the association was found only in USA women [7]. The
possible explanation for the gender difference is the rela-
tively sufficient folate intake in women. In the presentFigure 1 The comparison of mean values (+SEM) of adjusted K6 score
for age, sex, job strain, worksite support, years of education, proportion ofstudy, mean (±SD) values of adjusted intake of men and
women were 159.4 ± 54.1 and 192.9 ± 69.9 μg/1000 kcal-
day, respectively, therefore the higher intakes of female
subjects maybe mask the effect of folate intake on de-
pression. However, because of the relative small size of
female subjects in our study and the importance of fol-
ate intake in pregnant women, whether the dietary folate
intake affect mental health should be further investigated
in larger scale and well-designed studies.
The mechanism of folate intake relate to depressive
symptom was thought to be that a decreased folate in-
take results in an accumulation of homocysteine and
then elevated homocysteine levels, which cause vascular
disease of the brain, and/or transmitter alterations, could
cause depression [30]. Higher total plasma homocysteine
concentrations were associated with older age, male gen-
der [31] and dietary deficiency of folate, vitamins B12
and B6 [32]. It was described that the lesions of athero-
sclerosis could be induced by administering homocysteic
acid by animal experiment [33]. Early studies suggested
a relationship between depression and cerebrovascular
and cardiovascular disease [34], and deficiency of folate
and elevated homocysteine levels was considered to in-
crease the risk for vascular disease of the brain [35-37].
However, more recent evidences strongly supported a
different role of folate. Folate plays a role in the 1-car-
bon cycle, and eventually produces S-adenosyl-L-methio-
nine (SAMe), which is an important methyl donor and
thought to be involved in the synthesis of three key neu-
rotransmitters in the brain-dopamine, serotonin and
norepinephrine [38]. Homocysteine is a critical branch
point metabolite that can influence cellular levels of
SAMe and S-adenosylhomocysteine (SAH), which regu-
late the activity of methyltransferases important inbetween different folate intake subgroups. K6 score is adjusted
management position and annual household income.
Table 3 The multiple logistic regression analysis of energy-adjusted folate intake as to with or without depressive
mood
Odds Ratio [95% CI] P value
Age (year) 0.971 [0.958-0.985] <0.001**
Sex (male = 1, female = 2) 0.821 [0.570-1.182] 0.288
Job stress scores
Job Strain 1.096 [1.065-1.128] <0.001**
Worksite Support 0.837 [0.786-0.891] <0.001**
SES factors
Years of education (year) 0.985 [0.938-1.033] 0.528
Management position (others = 0, manager = 1) 0.916 [0.665-1.261] 0.590
Annual household income (million yen/year) 0.980 [0.937-1.025] 0.382
Energy-adjusted folate intake (100 μg/1000 kcalday) 0.813 [0.664-0.994] 0.044*
Constant 13.432 <0.001**
Depressive symptom is defined as K6 score ≥9 in a 24-scoring system. CI indicates confidence interval. P for model <0.001.
*P< 0.05; **P< 0.01.
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of nucleic acids, phospholipids, and neurotransmitters
[39]. Thus, low folate intakes, which result in elevated
homocysteine levels, lead to a deficiency of these neuro-
transmitters and then cause depression. The homocyst-
eine hypothesis of depression reviewed by Folstein et al.
[30] centering around hyperhomocysteinemia leading to
an increased risk of stroke, heart disease, neurotransmit-
ter imbalances and thereby depression was further
extended by a brief comment in the American Journal of
Psychiatry in 2007 [40]. The authors herein stated that
homocysteine is metabolized to SAMe, then influence
DNA methylation. Secondly, homocysteine itself was
shown to affect global and gene promoter DNA methy-
lation, and the administration of acute homocysteine
usually leads to demethylation of promoter DNA with a
subsequent increase in gene expression [41]. A further
study supported the hyperhomocysteine hypothesis of
depression, reporting significantly higher homocysteine
levels in patients with moderate depressive symptoms
and eating disorder diagnoses [42]. Our observations
epidemiologically confirmed with this hypothesis.
Some limitations of the present study are worth men-
tioning. Firstly, the cross-sectional nature of the study
does not permit the assessment of causality owing to the
uncertain temporality of the association. Depressed per-
sons may eat less or more and the intakes of nutrition
are influenced by the total amount of intake. In order to
remove this effect, we used the total energy adjusted fol-
ate intake level (μg/1000 kcal per day). Our data showed
energy adjusted low folate intake was significantly
related to depressive symptoms, and the probability of
the reverse causation seems slim. Secondly, our subjects
were workers in one large company and not a random
sample of Japanese workers, and thus the results maynot apply to the general Japanese population. However,
the workers were recruited from 12 offices all over the
Japan (From Hokkaido to Kyushu). So the geographical
deviation was reasonably diluted, but it is noteworthy
fact that our result is the result of a large company, not
a small company. Finally, dietary data were obtained
from a self-administered semi-quantitative dietary as-
sessment questionnaire [25]. Because the actual dietary
habits were not observed, the results should be inter-
preted with caution, although the validity of this ques-
tionnaire appears reasonable [26-28].
Conclusions
In conclusion, low folate intake was independently
related to higher depression scores and increased preva-
lence of depressive symptoms in Japanese workers,
adjusting for job strains, supports and various SES fac-
tors. Further prospective or intervention studies are war-
ranted to determine this association as well as the roles
of SES and stress effect on mental health outcomes.
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